{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:39:52Z","timestamp":1790836792083,"version":"4.1.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.biocel.2013.06.017","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T11:01:19Z","timestamp":1372503679000},"page":"1987-1996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years"],"prefix":"10.1016","volume":"45","author":[{"given":"Bo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2013.06.017_bib0005","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1007\/s10620-006-9718-8","article-title":"Adefovir dipivoxil alone or in combination with lamivudine for three months in patients with lamivudine resistant compensated chronic hepatitis B","volume":"52","author":"Akyildiz","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1016\/j.biocel.2013.06.017_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1665-2681(19)31360-2","article-title":"Single nucleotide polymorphisms in CXCR1 gene and its association with hepatitis B infected patients in Saudi Arabia","volume":"12","author":"Almajhdi","year":"2013","journal-title":"Annals of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0015","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4238\/2012.April.10.1","article-title":"RANTES gene polymorphisms (\u2212403G>A and \u221228C>G) associated with hepatitis B virus infection in a Saudi population","volume":"11","author":"Al-Qahtani","year":"2012","journal-title":"Genetics and Molecular Research"},{"key":"10.1016\/j.biocel.2013.06.017_bib0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1462-5822.2010.01557.x","article-title":"Alix regulates egress of hepatitis B virus naked capsid particles in an ESCRT-independent manner","volume":"13","author":"Bardens","year":"2011","journal-title":"Cellular Microbiology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2119\/2006-00015.Barone","article-title":"Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis","volume":"12","author":"Barone","year":"2006","journal-title":"Molecular Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","article-title":"Hepatitis B virus replication","volume":"13","author":"Beck","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A \u201cnew\u201d antigen in leukemia sera","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.biocel.2013.06.017_bib0040","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0045","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/hep.22326","article-title":"MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors","volume":"47","author":"Braconi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1128","article-title":"Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans","volume":"33","author":"Carlson","year":"2003","journal-title":"Nature Genetics"},{"key":"10.1016\/j.biocel.2013.06.017_bib0055","doi-asserted-by":"crossref","first-page":"e50787","DOI":"10.1371\/journal.pone.0050787","article-title":"Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.06.017_bib0060","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jcv.2006.12.007","article-title":"Improved multiplex-PCR to identify hepatitis B virus genotypes A-F and subgenotypes B1, B2, C1 and C2","volume":"38","author":"Chen","year":"2007","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0065","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Research"},{"key":"10.1016\/j.biocel.2013.06.017_bib0070","doi-asserted-by":"crossref","first-page":"e53008","DOI":"10.1371\/journal.pone.0053008","article-title":"Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.06.017_bib0075","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0092-8674(89)90770-8","article-title":"Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice","volume":"59","author":"Chisari","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2013.06.017_bib0080","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep.1840360617","article-title":"Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection","volume":"36","author":"Chu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0085","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1053\/jhep.2002.33161","article-title":"Clinical significance of hepatitis B virus genotypes","volume":"35","author":"Chu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(02)00461-9","article-title":"Comparative evaluation of a combined DTP-HB vaccine in the EPI in Chiangrai Province, Thailand","volume":"21","author":"Chunsuttiwat","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0095","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/hep.21422","article-title":"Entecavir resistance is rare in nucleoside naive patients with hepatitis B","volume":"44","author":"Colonno","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0100","first-page":"ra1","article-title":"Inhibition of PP1 phosphatase activity by HBx: a mechanism for the activation of hepatitis B virus transcription","volume":"5","author":"Cougot","year":"2012","journal-title":"Signal Transduction"},{"key":"10.1016\/j.biocel.2013.06.017_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/jhep.2002.30203","article-title":"Increase in de novo HBV DNA integrations in response to oxidative DNA damage or inhibition of poly (ADP-ribosyl)ation","volume":"35","author":"Dandri","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0110","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.00138-06","article-title":"Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus","volume":"50","author":"Delaney","year":"2006","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.biocel.2013.06.017_bib0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0120","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/clinchem\/46.12.2027","article-title":"Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests","volume":"46","author":"Dufour","year":"2000","journal-title":"Clinical Chemistry"},{"key":"10.1016\/j.biocel.2013.06.017_bib0125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.11.010","article-title":"Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis","volume":"253","author":"Feitelson","year":"2007","journal-title":"Cancer Letters"},{"key":"10.1016\/j.biocel.2013.06.017_bib0135","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants","volume":"23","author":"Fitzsimons","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","article-title":"Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B","volume":"51","author":"Fleischer","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0145","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/01.inf.0000183853.16113.a6","article-title":"Vaccine safety controversies and the future of vaccination programs","volume":"24","author":"Francois","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.biocel.2013.06.017_bib0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biocel.2012.02.004","article-title":"MicroRNA-modulated autophagic signaling networks in cancer","volume":"44","author":"Fu","year":"2012","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0155","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2005.10.018","article-title":"Virologic response and resistance to adefovir in patients with chronic hepatitis B","volume":"44","author":"Fung","year":"2006","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/281646a0","article-title":"Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli","volume":"281","author":"Galibert","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.06.017_bib0165","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection \u2013 natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0170","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4049\/jimmunol.1102205","article-title":"Granzyme H of cytotoxic lymphocytes is required for clearance of the hepatitis B virus through cleavage of the hepatitis B virus X protein","volume":"188","author":"Ganova-Raeva","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jhep.2012.01.029","article-title":"STAT proteins-key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver","volume":"57","author":"Gao","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0180","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jmv.20824","article-title":"Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan","volume":"79","author":"Hayashi","year":"2007","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2613.2009.00656.x","article-title":"Experimental mouse models for hepatocellular carcinoma research","volume":"90","author":"Heindryckx","year":"2009","journal-title":"International Journal of Experimental Pathology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0190","first-page":"451694","article-title":"The PD-1\/PD-L1 (B7-H1) pathway in chronic infection-induced cytotoxic T lymphocyte exhaustion","volume":"2011","author":"Hofmeyer","year":"2011","journal-title":"Journal of Biomedicine and Biotechnology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0195","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.97.4.1661","article-title":"Identification of hepatitis B virus indigenous to chimpanzees","volume":"97","author":"Hu","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.06.017_bib0200","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1053\/j.gastro.2011.06.048","article-title":"Hepatitis B virus core promoter mutations contribute to hepatocarcinogenesis by deregulating SKP2 and its target, p21","volume":"141","author":"Huang","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2893.2005.00633.x","article-title":"The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial","volume":"12","author":"Iino","year":"2005","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.biocel.2013.06.017_bib0210","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1478-3231.2012.02805.x","article-title":"Natural history of chronic hepatitis B: what exactly has REVEAL revealed","volume":"32","author":"Iloeje","year":"2012","journal-title":"Liver International"},{"key":"10.1016\/j.biocel.2013.06.017_bib0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2013.06.017_bib0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3748\/wjg.v13.i1.39","article-title":"Intracellular transport of hepatitis B virus","volume":"13","author":"Kann","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0225","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/17474124.2.4.553","article-title":"Diagnosis of hepatitis B virus infection through serological and virological markers","volume":"2","author":"Kao","year":"2008","journal-title":"Expert Review of Gastroenterology and Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbrc.2006.10.028","article-title":"The interaction of hepatitis B virus X protein and protein phosphatase type 2 Calpha and its effect on IL-6","volume":"351","author":"Kim","year":"2006","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.biocel.2013.06.017_bib0235","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1002\/pmic.200800779","article-title":"Proteomic analysis of liver tissue from HBx-transgenic mice at early stages of hepatocarcinogenesis","volume":"9","author":"Kim","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.biocel.2013.06.017_bib0240","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.4161\/cc.10.20.17856","article-title":"Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC","volume":"10","author":"Knoll","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biocel.2013.06.017_bib0245","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/he.2000.5982","article-title":"Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans","volume":"31","author":"Korba","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0255","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/hep.22256","article-title":"MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene\/tumor suppressor gene mutations","volume":"47","author":"Ladeiro","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0260","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1056\/NEJMoa066422","article-title":"Telbivudine versus lamivudine in patients with chronic hepatitis B","volume":"357","author":"Lai","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0265","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.gastro.2005.05.053","article-title":"A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B","volume":"129","author":"Lai","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0270","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3748\/wjg.v17.i20.2536","article-title":"microRNAs: fad or future of liver disease","volume":"17","author":"Lakner","year":"2011","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0275","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1101\/gad.856201","article-title":"The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis","volume":"15","author":"Lee","year":"2001","journal-title":"Genes and Development"},{"key":"10.1016\/j.biocel.2013.06.017_bib0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MCG.0b013e318225f559","article-title":"Simple scoring system predicting genotypic resistance during rescue therapy for lamivudine-resistant chronic hepatitis B","volume":"46","author":"Lee","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0285","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jps.21047","article-title":"Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting","volume":"97","author":"Li","year":"2008","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.biocel.2013.06.017_bib0290","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJMe020060","article-title":"Hepatitis B. e Antigen\u2014the dangerous endgame of hepatitis B","volume":"347","author":"Liang","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0295","first-page":"309","article-title":"Hepatitis B: the virus and disease","volume":"7","author":"Liang","year":"2009","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"10.1016\/j.biocel.2013.06.017_bib0300","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biocel.2013.06.017_bib0305","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0310","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.166.1.49","article-title":"A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B","volume":"166","author":"Lim","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0315","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hep.25751","article-title":"Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness","volume":"56","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0320","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1021\/pr2012297","article-title":"Hepatitis B virus encoded X protein suppresses apoptosis by inhibition of the caspase-independent pathway","volume":"11","author":"Liu","year":"2012","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.biocel.2013.06.017_bib0325","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/carcin\/bgr224","article-title":"Identification of the common regulators for hepatocellular carcinoma induced by hepatitis B virus X antigen in a mouse model","volume":"33","author":"Lu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biocel.2013.06.017_bib0330","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/hep.23611","article-title":"In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice","volume":"52","author":"Lutgehetmann","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0340","doi-asserted-by":"crossref","first-page":"e33430","DOI":"10.1371\/journal.pone.0033430","article-title":"Species association of hepatitis B virus (HBV) in non-human apes; evidence for recombination between gorilla and chimpanzee variants","volume":"7","author":"Lyons","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.06.017_bib0345","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/abbs\/gmr048","article-title":"The role of hepatitis B virus X protein is related to its differential intracellular localization","volume":"43","author":"Ma","year":"2011","journal-title":"Acta Biochimica et Biophysica Sinica (Shanghai)"},{"key":"10.1016\/j.biocel.2013.06.017_bib0350","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/JVI.74.9.4253-4257.2000","article-title":"Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes","volume":"74","author":"MacDonald","year":"2000","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.gene.2004.12.021","article-title":"Re-analysis of a human hepatitis B virus (HBV) isolate from an East African wild born Pan troglodytes schweinfurthii: evidence for interspecies recombination between HBV infecting chimpanzee and human","volume":"349","author":"Magiorkinis","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.biocel.2013.06.017_bib0360","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1073\/pnas.0409332102","article-title":"Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection","volume":"102","author":"Mason","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2013.06.017_bib0365","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1128\/AAC.00263-09","article-title":"Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B","volume":"53","author":"Michalak","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.biocel.2013.06.017_bib0370","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1007\/s10900-011-9507-y","article-title":"An analysis of content in comprehensive cancer control plans that address chronic hepatitis B and C virus infections as major risk factors for liver cancer","volume":"37","author":"Momin","year":"2012","journal-title":"Journal of Community Health"},{"key":"10.1016\/j.biocel.2013.06.017_bib0375","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s005350170027","article-title":"Hepatitis B virus X protein: a multifunctional viral regulator","volume":"36","author":"Murakami","year":"2001","journal-title":"Journal of Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0380","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1099\/0022-1317-67-3-453","article-title":"Detection of antiviral antibodies with predetermined specificity using synthetic peptide--beta-lactamase conjugates: application to antibodies specific for the preS region of the hepatitis B virus envelope proteins","volume":"67","author":"Neurath","year":"1986","journal-title":"Journal of General Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0385","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/jvi.69.6.3350-3357.1995","article-title":"The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes","volume":"69","author":"Newbold","year":"1995","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0390","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1371\/journal.pmed.0020163","article-title":"Host heterogeneous ribonucleoprotein K (hnRNPK) as a potential target to suppress hepatitis B virus replication","volume":"2","author":"Ng","year":"2005","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0395","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/jhep.2001.20532","article-title":"A case\u2013control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C","volume":"33","author":"Orito","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0400","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nature06205","article-title":"Interferon modulation of cellular microRNAs as an antiviral mechanism","volume":"449","author":"Pedersen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.06.017_bib0405","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1128\/JVI.77.3.2287-2294.2003","article-title":"Duck hepatitis B virus virion secretion requires a double-stranded DNA genome","volume":"77","author":"Perlman","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0410","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1053\/j.gastro.2007.07.021","article-title":"Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection","volume":"133","author":"Protzer","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0415","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2180-11-48","article-title":"Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH","volume":"11","author":"Qadri","year":"2011","journal-title":"BMC Microbiology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0420","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1128\/JVI.74.6.2840-2846.2000","article-title":"Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel HVDAC3, and alters its transmembrane potential","volume":"74","author":"Rahmani","year":"2000","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0425","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.vaccine.2009.01.063","article-title":"New perspectives for hepatitis B vaccines and immunization","volume":"27","author":"Rapicetta","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0430","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1128\/JVI.75.3.1104-1116.2001","article-title":"Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors","volume":"75","author":"Ren","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0435","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0440","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.patbio.2010.04.005","article-title":"The woodchuck: a model for therapeutic vaccination against hepadnaviral infection","volume":"58","author":"Roggendorf","year":"2010","journal-title":"Pathologie Biologie"},{"key":"10.1016\/j.biocel.2013.06.017_bib0445","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4149\/av_2009_02_73","article-title":"Hepatitis B virus infection in non-human primates","volume":"53","author":"Sa-Nguanmoo","year":"2009","journal-title":"Acta Virologica"},{"key":"10.1016\/j.biocel.2013.06.017_bib0450","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10571-006-9033-0","article-title":"Biochemical and clinical improvement of cytotoxic state by amantadine sulphate","volume":"26","author":"Saniova","year":"2006","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0455","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1074\/jbc.274.17.11945","article-title":"Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus Structure and glycosylation patterns of surface proteins from woodchuck hepatitis virus","volume":"274","author":"Schmitt","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2013.06.017_bib0460","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.3961490","article-title":"Biochemical and genetic evidence for the hepatitis B virus replication strategy","volume":"232","author":"Seeger","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.biocel.2013.06.017_bib0465","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep.22323","article-title":"Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks","volume":"48","author":"Sherman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/jhep.2003.50036","article-title":"Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease","volume":"37","author":"Sumi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0475","doi-asserted-by":"crossref","first-page":"21941","DOI":"10.1074\/jbc.M109.014563","article-title":"Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling","volume":"284","author":"Sung","year":"2009","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2013.06.017_bib0480","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.22581","article-title":"Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression","volume":"49","author":"Tang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0485","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/pr8008622","article-title":"Proteomic profilingidentifies aberrant epigenetic modifications induced by hepatitis B virus X protein","volume":"8","author":"Tong","year":"2009","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.biocel.2013.06.017_bib0490","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1744-313X.2008.00770.x","article-title":"Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome","volume":"35","author":"Truelove","year":"2008","journal-title":"International Journal of Immunogenetics"},{"key":"10.1016\/j.biocel.2013.06.017_bib0495","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2009.10.031","article-title":"The replication cycle of hepatitis B virus","volume":"52","author":"Urban","year":"2010","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0500","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/280815a0","article-title":"Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen","volume":"280","author":"Valenzuela","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2013.06.017_bib0505","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.21253","article-title":"Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy","volume":"44","author":"van B\u00f6mmel","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0510","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.20128","article-title":"Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B","volume":"39","author":"van Zonneveld","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0515","doi-asserted-by":"crossref","first-page":"11155","DOI":"10.1128\/JVI.76.21.11155-11158.2002","article-title":"Identification of a hepatitis B virus genome in wild chimpanzees (Pan troglodytes schweinfurthi) from East Africa indicates a wide geographical dispersion among equatorial African primates","volume":"76","author":"Vartanian","year":"2002","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0520","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1086\/597614","article-title":"Methylation regulates hepatitis B viral protein expression","volume":"199","author":"Vivekanandan","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.biocel.2013.06.017_bib0525","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with Hepatitis B virus","author":"Volz","year":"2012","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0530","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/hep.23100","article-title":"Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL\/6 mice","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0535","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.24675","article-title":"Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice","volume":"55","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0540","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3892\/or.2012.1620","article-title":"Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway","volume":"27","author":"Wang","year":"2012","journal-title":"Oncology Reports"},{"key":"10.1016\/j.biocel.2013.06.017_bib0545","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1128\/JVI.02164-09","article-title":"Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases","volume":"84","author":"Wang","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0550","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1093\/nar\/gkq285","article-title":"CREB upregulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.biocel.2013.06.017_bib0555","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11010-012-1457-x","article-title":"HBx induces HepG-2 cells autophagy through PI3K\/Akt-mTOR pathway","volume":"372","author":"Wang","year":"2013","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.biocel.2013.06.017_bib0560","doi-asserted-by":"crossref","first-page":"e36818","DOI":"10.1371\/journal.pone.0036818","article-title":"Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to fas signaling","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.biocel.2013.06.017_bib0565","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1743-422X-9-170","article-title":"Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): A model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans","volume":"9","author":"Wang","year":"2012","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0570","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2012.07.010","article-title":"Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life","volume":"30","author":"Wang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biocel.2013.06.017_bib0575","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.22751","article-title":"Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0580","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.1101652","article-title":"Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx\/ERK\/NF-(B pathway","volume":"188","author":"Xia","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0585","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26303","article-title":"Interaction of signal transducer and activator of transcription 3 polymorphisms with HBV mutations in hepatocellular carcinoma","author":"Xie","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0590","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jprot.2011.09.011","article-title":"Comprehensive proteomic analysis of host cell lipid rafts modified by HBV infection","volume":"75","author":"Xie","year":"2012","journal-title":"Journal of Proteomics"},{"key":"10.1016\/j.biocel.2013.06.017_bib0595","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.gastro.2012.03.053","article-title":"Hepatitis B virus X protein confers resistance of hepatoma cells to anoikis by up-regulating and activating p21-activated kinase 1","volume":"143","author":"Xu","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0600","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.biocel.2013.06.017_bib0605","first-page":"613","article-title":"The tree shrews: useful animal models for the viral hepatitis and hepatocellular carcinoma","volume":"52","author":"Yang","year":"2005","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0610","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1517\/14656566.5.11.2361","article-title":"Adefovir dipivoxil in chronic hepatitis B infection","volume":"5","author":"Yuen","year":"2004","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.biocel.2013.06.017_bib0615","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/AAC.01290-08","article-title":"Pharmacokinetics of LB80331 and LB80317 following oral administration of LB80380, a new antiviral agent for chronic hepatitis B (CHB), in healthy adult subjects, CHB patients, and mice","volume":"53","author":"Yuen","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.biocel.2013.06.017_bib0620","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jprot.2013.03.028","article-title":"An integrated proteomics and bioinformatics analyses of Hepatitis B Virus X protein and identification of a novel interactor apoA-I","volume":"84","author":"Zhang","year":"2013","journal-title":"Journal of Proteomics"},{"key":"10.1016\/j.biocel.2013.06.017_bib0625","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcv.2007.08.016","article-title":"Single nucleotide polymorphisms and functional analysis of class II transactivator (CIITA) promoter IV in persistent HBV infection","volume":"40","author":"Zhang","year":"2007","journal-title":"Journal of Clinical Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0630","doi-asserted-by":"crossref","first-page":"9326","DOI":"10.1128\/JVI.00579-10","article-title":"Inhibition of cellular proteasome activities mediates HBX-independent hepatitis B virus replication in vivo","volume":"84","author":"Zhang","year":"2010","journal-title":"Journal of Virology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0635","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2893.2008.01040.x","article-title":"A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection","volume":"16","author":"Zhou","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.biocel.2013.06.017_bib0640","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12272-012-0206-8","article-title":"Humanized murine model for HBV and HCV using human induced pluripotent stem cells","volume":"35","author":"Zhou","year":"2012","journal-title":"Archives of Pharmacal Research"},{"key":"10.1016\/j.biocel.2013.06.017_bib0645","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1128\/AAC.42.7.1805","article-title":"Anti-hepatitis B virus activity and metabolism of 2\u2032,3\u2032-dideoxy-2\u2032,3\u2032-didehydro-beta-l(-)-5-fluorocytidine","volume":"42","author":"Zhu","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.biocel.2013.06.017_bib0650","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2004.12.015","article-title":"New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA","volume":"42","author":"Zoulim","year":"2005","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.biocel.2013.06.017_bib0655","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727251300201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727251300201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:51:24Z","timestamp":1761202284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135727251300201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":130,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S135727251300201X"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2013.06.017","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2013.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}